The Effectiveness of Ferric Carboxymaltose on the Improvement of Chronic Iron Deficiency Anemia in Patients With Colon Cancer: A Controlled Randomized Clinical Trial

نویسندگان
Sadat Rasul, Maryam Sadat ID 1
Ramim, Tayeb ID 2
Ansarinejad, Nafiseh ID 3
Abbasi, Bahareh ID 4
Fardad, Farshid ID 5

1 Hospital Pharmacy Management, Iran University Medical Sciences, Tehran, IR Iran

2 Cancer Pharmacogenetics Research Group (CPGRG), Iran University of Medical Sciences, Tehran, IR Iran

3 Department of Hematology and Oncology, Hazrat Rasool-e Akram Hospital, Iran University of Medical Sciences, Tehran, IR Iran

4 Cancer Pharmacogenetics Research Group (CPGRG), Iran University of Medical Sciences, Tehran, IR Iran

5 Department of Hematology and Oncology, Hazrat Rasool-e Akram Hospital, Iran University of Medical Sciences, Tehran, IR Iran

doi
10.17795/jogcr-8006
چکیده

Background: Anemia is prevalent in 32% to 60% of patients with cancer due to an underlying disease, nutritional deficiencies and complications of medication used in chemotherapy. National Comprehensive Cancer Network (NCCN) recommends the use of oral or intravenous iron supplementation in patients with iron deficiency anemia.

کلیدواژه‌ها
Iron Deficiency Anemia, Colon cancer, Iron Injections, Oral Iron, Ferric Carboxymaltose, ferrous sulfate